MDUFMA First Action: FDA Sets Review Milestones For Submissions
This article was originally published in The Gray Sheet
Executive Summary
CDRH is mapping out review timeline "milestones" for PMAs and 510(k)s as part of efforts to meet fiscal year 2005 MDUFMA goals
You may also be interested in...
Premarket Notification “Not Substantially Equivalent” Rates Trending Upward
The rate of 510(k)s found "not substantially equivalent" has been rising over the last four fiscal years, an FDL-1Office of Device Evaluation annual report suggests
Premarket Notification “Not Substantially Equivalent” Rates Trending Upward
The rate of 510(k)s found "not substantially equivalent" has been rising over the last four fiscal years, an FDL-1Office of Device Evaluation annual report suggests
Girding For MDUFMA II: Premarket Review Unit Cost Study In Planning Phase
FDA's unit cost analysis of premarket review resources may incite a long-term change to device user fee rates if certain application types prove more expensive to assess than previously believed